Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) ...

If you spend more than you can pay off, credit card interest can cancel out any tariff savings. Plus, spending a lot early in ...

The new Buy Now, Pay Later option will also charge interest, with APR rates between 10% and 36%. A $500 purchase at 20% APR, with payments spread out across 6 months, for example, will cost $88.27 per ...

The popularity of nicotine pouches has surged, with the American Lung Association reporting a 641% increase in use from 2019 to 2022, predominantly ...

Without insurance, Mounjaro costs approximately $1,069.08 per 4-week supply. You can get Mounjaro online through a licensed medical professional on a telehealth platform. PlushCare offers Mounjaro ...

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Ishares S&p 500 Etf wasn't one of them. The online investing ...

Gold and silver are traditionally considered the most auspicious purchases on Akshaya Tritiya. Buying these metals symbolises prosperity and long-term wealth. Many people invest in coins ...

Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...

Stock markets experienced a largely subdued trading day on Tuesday, as intraday gains were erased, resulting in a flat close. Nevertheless, the Nifty 50 index managed to stay above the 24,300 mark.

The sportswear brand's new collab with Hasbro features limited-edition sneakers that celebrate the NBA superstar's love for the board game. By Rudie Obias If you purchase an independently reviewed ...

The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus Therapeutics for a rare renal disease drug that is set to enter phase 3 in the third quarter. Regulus ...

April 30 (Reuters) - Novartis (NOVN.S), opens new tab has agreed to buy Regulus Therapeutics (RGLS.O), opens new tab for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...